Gene therapy offers HD patients relief from some symptoms. Tetrabenazine inhibits the transport of a molecule called vesicular monoamine transporter type 2 or VMAT2.
作者
Thomas Morrow
出处
期刊:PubMed [National Institutes of Health] 日期:2008-11-01卷期号:17 (11): 46-7被引量:1